nifedipine has been researched along with methyldopa in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (28.38) | 18.7374 |
1990's | 5 (6.76) | 18.2507 |
2000's | 15 (20.27) | 29.6817 |
2010's | 23 (31.08) | 24.3611 |
2020's | 10 (13.51) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arakaki, Y; Nakamura, N; Takaesu, N | 1 |
Babaian, AS; Dzhandzhapanian, AZ; Gurgenian, SV; Mikaelian, ES | 1 |
Ram, CV | 1 |
Deschamps de Paillette, E; Grimberg, D; Tarrade, T | 1 |
Cerný, J; Dolezel, S; Dostál, M; Guba, P; Petrzilka, J; Sotolová, O; Urbánek, P; Vasků, A; Vasků, J | 1 |
Cerný, J; Dostál, M; Gregor, Z; Guba, P; Rebícek, J; Sotolová, O; Urbánek, P; Vasků, A; Vasků, J | 1 |
Robinson, BF | 1 |
Naden, RP; Redman, CW | 1 |
Janssens, M; Symoens, J | 1 |
Cámera, MI; Martinotti, A; Mayorga, LM; Vignolo, CA; Waisman, GD | 1 |
Beevers, DG; Constantine, G; Luesley, DM; Reynolds, AL | 1 |
Heckmann, U; Ottens, E; Zidek, W | 1 |
Guillén Llera, F; Reuss, JM; Tobares, N; Torres, M; Viguera, S | 1 |
Conway, J | 1 |
Marxer, A; Schier, O | 1 |
Eliahou, HE; Iaina, A | 1 |
Hallbäck-Nordlander, MI; Lundin, SA | 1 |
Day, TW; Mendoza, F | 1 |
Matsui, S; Murakami, E; Murakami, H; Takekoshi, N | 1 |
Bayley, S; Dobbs, RJ; Robinson, BF | 1 |
Guazzi, M | 1 |
Chatani, T; Emoto, J; Fujita, S; Hashimoto, A; Masuya, K; Matsui, S; Murakami, E; Murakami, H; Nomura, M; Takekoshi, N; Tsugawa, H; Tsuji, S | 1 |
Bartorelli, A; Fiorentini, C; Guazzi, MD; Necchi, G; Olivari, MT; Polese, A | 1 |
Jayawardana, J; Lekamge, N | 1 |
Chandran, R; Kyle, PM; Redman, CW; Serra-Serra, V | 1 |
Hall, DR; Odendaal, HJ | 1 |
Grové, D; Hall, DR; Odendaal, HJ; Steyn, DW | 1 |
Grové, D; Hall, DR; Kirsten, GF; Odendaal, HJ; Smith, J | 1 |
Candy, G; Libhaber, E; Radevski, I; Sareli, P; Skudicky, D; Staessen, JA; Thijs, L; Tshele, E; Valtchanova, Z; Wang, JG | 1 |
Okoro, EO; Oyejola, BA | 2 |
de Swiet, M; Goulis, DG; Redman, CW; Walker, IA; Williamson, C | 1 |
Dennedy, MC; Houlihan, DD; Morrison, JJ; Ravikumar, N | 1 |
Chen, SC; Lee, TH; Li, CY; Shibuya, T; Shih, HC | 1 |
Gembruch, U; Merz, WM | 1 |
Dalmia, S; Deka, D; Gupta, N; Mittal, S | 1 |
Monostory, K; Ozsvár, Z; Solymossi, Z | 1 |
Folic, MD; Folic, MM; Jankovic, SM; Varjacic, MR | 1 |
Carvajal-Valencia, JA; Chacón-Solís, AR; Estrada-Altamirano, A; Hernández-Pacheco, JA; Maya-Quiñones, JL; Valenzuela-Jirón, A | 1 |
Alexander, JM; Wilson, KL | 1 |
Arulkumaran, N; Lightstone, L | 1 |
Cosmi, E; D'Antona, D; Gizzo, S; Noventa, M; Paccagnella, G; Patrelli, TS; Saccardi, C | 1 |
Brussé, IA; Duvekot, JJ; Grune, F; Sonneveld, MJ; Steegers, EA; Visser, GH | 1 |
Firoz, T; Gordon, R; MacDonell, K; Magee, LA; Payne, BA; Vidler, M; von Dadelszen, P | 1 |
Jim, B; Reddy, S | 1 |
Bracken, H; Easterling, T; Magee, LA; Mool, S; Mundle, S; Parvekar, S; Shochet, T; von Dadelszen, P; Winikoff, B | 1 |
Karumanchi, SA; Lemoine, ER | 1 |
Abdallah, S; Gaber, W; Gamal, A; Hamza, H; Marawan, H; Rezk, M; Salama, M | 1 |
Mol, BW; Saade, GR | 1 |
Rezk, M | 1 |
Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V | 1 |
Alers, RJ; Cauffman, E; Ghossein-Doha, C; Lopes van Balen, VA; Mulder, EG; Oben, J; Schiffer, VMMM; Smits, L; Spaanderman, MEA; van Kuijk, SMJ | 1 |
Ashworth, D; Battersby, C; Chappell, LC; Cluver, C; Green, M; Hardy, P; McManus, RJ | 1 |
Avalos, LA; Badon, SE; Bider-Canfield, Z; Cheetham, TC; Chen, L; Dublin, S; Easterling, TR; Holt, VL; Idu, A; Nance, N; Neugebauer, RS; Reynolds, K; Shortreed, SM | 1 |
Hirakawa, H; Ito, M; Josaka, R; Kikuchi, D; Miura, R; Obara, T; Okada, K; Suzuki, N; Tokunaga, M; Usui, K | 1 |
Allegaert, K; Flint, RB; Mian, P; Schoenmakers, S; van de Vusse, D; Versmissen, J; Visser, W | 1 |
Shigemi, D; Taguchi, R; Yasunaga, H | 1 |
Bhat, AD; Dombrowski, MM; Keasler, PM; Kolluru, L; Palanisamy, A; Singh, PM | 1 |
15 review(s) available for nifedipine and methyldopa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Calcium antagonists in the treatment of hypertension.
Topics: Biological Transport, Active; Calcium; Calcium Channel Blockers; Captopril; Diltiazem; Diuretics; Drug Resistance; Drug Therapy, Combination; Electrophysiology; Humans; Hypertension; Hypertension, Renovascular; Ion Channels; Kinetics; Methyldopa; Muscle, Smooth, Vascular; Nifedipine; Propranolol; Sodium; Vascular Resistance; Verapamil | 1985 |
Calcium-entry blocking agents in the treatment of systemic hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Methyldopa; Nifedipine; Renin; Sodium; Verapamil | 1985 |
Antihypertensive drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Regional Blood Flow; Uterus | 1985 |
Antihypertensive agents 1969-1980.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Ergolines; Fusaric Acid; Guanidines; Humans; Hydralazine; Indoramin; Methyldopa; Minoxidil; Nifedipine; Piperazines; Prazosin; Prostaglandins | 1981 |
From beta blockers to Ca2+ blockers in hypertension: a review.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Circulation; Drug Therapy, Combination; Humans; Hypertension; Hypotension; Methyldopa; Nifedipine; Vascular Resistance; Verapamil | 1982 |
Pharmacologic management of Raynaud's phenomenon.
Topics: Blood Platelets; Blood Viscosity; Fibrinogen; Griseofulvin; Humans; Methyldopa; Nifedipine; Parasympatholytics; Phenoxybenzamine; Raynaud Disease; Receptors, Adrenergic; Reserpine | 1984 |
Hypertensive emergencies of pregnancy.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Creatine; Diuretics; Emergency Medicine; Female; Fetal Monitoring; Humans; Hydralazine; Infusions, Intravenous; Labetalol; Methyldopa; Nifedipine; Nitroprusside; North America; Oliguria; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria | 2013 |
Severe pre-eclampsia and hypertensive crises.
Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Critical Care; Early Diagnosis; Eclampsia; Female; HELLP Syndrome; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Nitroglycerin; Pre-Eclampsia; Pregnancy; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome; United Kingdom | 2013 |
Twin pregnancy after kidney transplantation: what's on? A case report and review of literature.
Topics: Adult; Anemia; Female; Humans; Hypertension, Pregnancy-Induced; Iron; Kidney Transplantation; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy, Twin; Transplant Recipients | 2014 |
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents | 2014 |
Hypertension and Pregnancy: Management and Future Risks.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Chronic Disease; Diuretics; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Platelet Aggregation Inhibitors; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Care; Renal Insufficiency, Chronic; Risk Factors; Vasodilator Agents | 2019 |
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease; Female; Fetal Growth Retardation; Furosemide; Gestational Age; Humans; Hypertension; Incidence; Infant, Small for Gestational Age; Ketanserin; Methyldopa; Network Meta-Analysis; Nifedipine; Perinatal Death; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Severity of Illness Index | 2020 |
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular | 2022 |
Treatment of acute-onset hypertension in pregnancy: A network meta-analysis of randomized controlled trials comparing anti-hypertensives and route of administration.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Ketanserin; Methyldopa; Network Meta-Analysis; Nifedipine; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic | 2023 |
11 trial(s) available for nifedipine and methyldopa
Article | Year |
---|---|
[Cicletanine administered with other antihypertensive agents].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Clonidine; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Nifedipine; Pyridines | 1989 |
Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
Topics: Blood Pressure; Body Weight; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Ketanserin; Male; Methyldopa; Middle Aged; Nifedipine | 1986 |
[Effectiveness and tolerance of slow-release nifedipine in the treatment of moderate arterial hypertension in the elderly. A comparative multicenter study].
Topics: Aged; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Hypertension; Male; Methyldopa; Nifedipine | 1986 |
Third-line therapy. A cautionary note.
Topics: Atenolol; Bendroflumethiazide; Captopril; Chlorthalidone; Female; Humans; Hypertension; Male; Methyldopa; Nifedipine | 1985 |
Nifedipine in the treatment of hypertension: report of a double-blind controlled trial.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Nifedipine; Pyridines | 1982 |
Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension.
Topics: Drug Therapy, Combination; Edema; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Methyldopa; Middle Aged; Nifedipine; Posture; Pyridines | 1980 |
A comparison of nifedipine with methyldopa in pregnancy induced hypertension.
Topics: Adult; Female; Humans; Hypertension; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies | 1994 |
The addition of a diuretic to anti-hypertensive therapy for early severe hypertension in pregnancy.
Topics: Adult; Amiloride; Antihypertensive Agents; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Gestational Age; Humans; Hydrochlorothiazide; Hypertension; Length of Stay; Methyldopa; Nifedipine; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Treatment Outcome | 1998 |
Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diastole; Diuretics; Echocardiography; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Methyldopa; Middle Aged; Nifedipine; Patient Compliance; Regression Analysis; South Africa; Systole; Verapamil | 2002 |
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension, Pregnancy-Induced; India; Infant, Newborn; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Outcome; Treatment Outcome; Young Adult | 2019 |
Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Egypt; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Infant, Newborn; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Diagnosis; Treatment Outcome; Young Adult | 2019 |
48 other study(ies) available for nifedipine and methyldopa
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Priapism in haemodialysis patient due to prazosin?
Topics: Adult; Drug Therapy, Combination; Heparin; Humans; Hypertension; Male; Methyldopa; Nifedipine; Prazosin; Priapism; Renal Dialysis | 1991 |
Efficacy of intravenous verapamil in arterial hypertension refractory to three-step antihypertensive therapy.
Topics: Adult; Antihypertensive Agents; Clonidine; Echocardiography; Female; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Infusions, Intravenous; Male; Methyldopa; Middle Aged; Nifedipine; Ventricular Function, Left; Verapamil | 1991 |
Therapy of venous hypertension in calves with total artificial heart (TAH).
Topics: Animals; Antihypertensive Agents; Captopril; Cardiac Pacing, Artificial; Cattle; Central Venous Pressure; Clonidine; Heart, Artificial; Hypertension; Liver Function Tests; Methyldopa; Nifedipine; Postoperative Complications; Prazosin | 1989 |
[Therapy of venous hypertension in animals with an artificial heart and long-term survival].
Topics: Animals; Antihypertensive Agents; Captopril; Cattle; Clonidine; Diltiazem; Heart, Artificial; Methyldopa; Nifedipine; Prazosin; Venous Pressure | 1989 |
Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia?
Topics: Adult; Drug Synergism; Female; Humans; Hypertension; Magnesium Sulfate; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy | 1988 |
Nifedipine as a second line antihypertensive drug in pregnancy.
Topics: Adult; Atenolol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypertension; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular | 1987 |
The effect of antihypertensive treatment on the circulating hypertensive factor in the spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Cross Circulation; Furosemide; Hypertension; Male; Methyldopa; Nifedipine; Propranolol; Rats; Rats, Inbred SHR | 1987 |
Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Cardiovascular System; Circadian Rhythm; Felodipine; Heart Rate; Hypertension; Methyldopa; Metoprolol; Nifedipine; Rats; Rats, Inbred SHR; Time Factors | 1984 |
Nifedipine in hypertension and heart failure.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Hypertension; Isosorbide Dinitrate; Male; Methyldopa; Middle Aged; Myocardial Infarction; Nifedipine; Propranolol; Renin-Angiotensin System | 1984 |
[Nifedipine in the treatment of hypertension].
Topics: Calcium Channel Blockers; Drug Therapy, Combination; Humans; Hypertension; Methyldopa; Muscle, Smooth, Vascular; Nifedipine; Pyridines | 1982 |
Treatment of severe hypertension and hypertensive emergency with nifedipine, a calcium antagonistic agent.
Topics: Administration, Oral; Adult; Aged; Calcium; Drug Synergism; Drug Therapy, Combination; Emergencies; Enema; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Nifedipine; Propranolol; Pyridines | 1981 |
The effect of nifedipine and methyldopa on maternal cerebral circulation.
Topics: Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Female; Heart Rate; Humans; Hypertension; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Ultrasonography, Interventional; Vasodilator Agents | 1997 |
Expectant management of early onset, severe pre-eclampsia: maternal outcome.
Topics: Adolescent; Adult; Antihypertensive Agents; Calcium Channel Blockers; Dihydralazine; Female; Fetal Distress; Humans; Magnesium Sulfate; Methyldopa; Monitoring, Physiologic; Nifedipine; Prazosin; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prospective Studies | 2000 |
Expectant management of early onset, severe pre-eclampsia: perinatal outcome.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Female; Fetal Monitoring; Humans; Infant Mortality; Infant, Newborn; Intensive Care, Neonatal; Length of Stay; Male; Methyldopa; Multivariate Analysis; Nifedipine; Prazosin; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prospective Studies | 2000 |
Inadequate control of blood pressure in Nigerians with diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Body Mass Index; Calcium Channel Blockers; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Hypoglycemic Agents; Insulin; Male; Methyldopa; Middle Aged; Nifedipine; Nigeria; Patient Compliance; Self Care | 2004 |
Treating high blood pressure in Africans with type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Calcium Chloride; Diabetes Mellitus, Type 2; Diuretics; Humans; Hypertension; Methyldopa; Nifedipine; Nigeria; Sodium Chloride Symporter Inhibitors | 2004 |
Preeclampsia with abnormal liver function tests is associated with cholestasis in a subgroup of cases.
Topics: Adrenergic alpha-Agonists; Adult; Anti-Inflammatory Agents; Bile Acids and Salts; Biomarkers; Blood Platelets; Calcium Channel Blockers; Cholestasis; Dexamethasone; Female; Humans; Liver Function Tests; Maternal Welfare; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy; Treatment Outcome; United Kingdom | 2004 |
Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance.
Topics: Adult; Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Fetus; Humans; Hydralazine; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Regional Blood Flow; Umbilical Arteries; Vascular Resistance | 2004 |
Anti-hypertension effects of traditional Chinese medicine ju-ling-tang on renal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Biopsy; Coronary Vessels; Disease Models, Animal; Drugs, Chinese Herbal; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Kidney; Male; Methyldopa; Nifedipine; Rats; Rats, Wistar | 2005 |
Severe, early-onset hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome episode with spontaneous remission during pregnancy.
Topics: Adult; Antihypertensive Agents; Female; Fetal Death; HELLP Syndrome; Humans; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Second; Proteinuria; Remission, Spontaneous; Severity of Illness Index; Vasodilator Agents | 2007 |
Successful maternal and fetal outcome in a pregnancy with type V Takayasu's aortoarteritis.
Topics: Adult; Antihypertensive Agents; Arterial Occlusive Diseases; Calcium Channel Blockers; Diuretics; Female; Furosemide; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Live Birth; Male; Methyldopa; Mitral Valve Insufficiency; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular; Takayasu Arteritis; Ventricular Dysfunction, Left | 2008 |
[Methyldopa-induced acute reactive hepatitis in pregnancy, drug-metabolizing capacity of the liver].
Topics: Adrenergic alpha-Agonists; Adult; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Blood Pressure; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Drug Administration Schedule; Female; Humans; Hypertension, Pregnancy-Induced; Methyldopa; Nifedipine; Oxidoreductases, N-Demethylating; Pregnancy; Pregnancy Complications, Cardiovascular; Transaminases; Treatment Outcome | 2010 |
Effects of methyldopa and nifedipine on uteroplacental and fetal hemodynamics in gestational hypertension.
Topics: Adult; Antihypertensive Agents; Female; Hemodynamics; Humans; Hypertension, Pregnancy-Induced; Methyldopa; Nifedipine; Placental Circulation; Pregnancy; Prospective Studies | 2012 |
[Takayasu's arteritis in pregnancy: report seven cases].
Topics: Adult; Antihypertensive Agents; Cesarean Section; Female; Fetal Growth Retardation; Follow-Up Studies; Humans; Hypertension, Renovascular; Infant, Newborn; Male; Methyldopa; Mexico; Nifedipine; Pre-Eclampsia; Prednisone; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Radiography; Takayasu Arteritis; Young Adult | 2011 |
Cerebral perfusion pressure in women with preeclampsia is elevated even after treatment of elevated blood pressure.
Topics: Adult; Antihypertensive Agents; Arterial Pressure; Blood Flow Velocity; Case-Control Studies; Cerebral Arteries; Cerebrum; Female; Humans; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy; Regional Blood Flow | 2014 |
Oral regimen management of acute hypertension in pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular | 2019 |
Letter to the Editor regarding research integrity.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy | 2020 |
Reply to letter regarding 'Methyldopa versus Nifedipine or no medication for treatment of chronic hypertension during pregnancy'.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy | 2020 |
Preventing Recurrent Preeclampsia by Tailored Treatment of Nonphysiologic Hemodynamic Adjustments to Pregnancy.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Hemodynamics; Humans; Labetalol; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy; Secondary Prevention | 2021 |
Which antihypertensive treatment is better for mild to moderate hypertension in pregnancy?
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Pregnancy; Prenatal Care; Treatment Outcome | 2022 |
Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
Topics: Antihypertensive Agents; Birth Weight; Female; Humans; Hypertension, Pregnancy-Induced; Infant; Infant, Newborn; Infant, Newborn, Diseases; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Outcome; Premature Birth; Retrospective Studies | 2022 |
Antihypertensive drug prescription trends for pregnant women with hypertension in acute hospitals in Japan.
Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Drug Prescriptions; Female; Hospitals; Humans; Hypertension; Japan; Methyldopa; Nifedipine; Pregnancy; Pregnant Women | 2022 |
Trends in antihypertensive prescription for pregnant women with hypertension and their peripartum outcomes before and after label and guideline revisions in Japan.
Topics: Antihypertensive Agents; Cesarean Section; Drug Prescriptions; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Japan; Methyldopa; Nifedipine; Peripartum Period; Pregnancy; Pregnancy Outcome; Pregnant Women; Premature Birth; Retrospective Studies | 2022 |